Overview
A Multicenter, Open Label Trial To Evaluate Pain Relief With Intravenous Followed By Oral Therapy With Parecoxib/Valdecoxib 40 Mg/Day For Treatment Of Post-Laparoscopic Surgery Pain
Status:
Terminated
Terminated
Trial end date:
2004-07-01
2004-07-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The objectives of this study were to assess the analgesic efficacy and safety of parecoxib/valdecoxib on post-laparoscopic surgery analgesia.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
PfizerTreatments:
Parecoxib
Valdecoxib
Criteria
Inclusion Criteria:- Patients who had undergone laparoscopic surgery
- Patients in need of post-surgical analgesia
Exclusion Criteria:
- Patients with an unexpected surgical complication which, in the Investigator's
opinion, placed the patient at significantly higher risk for post-surgical
complication(s), or for non-routine post-operative care requirements
- Patients who took any nonsteroidal anti-inflammatory drug or any analgesic within 48
hours prior to surgery